Dr. Wu Skincare (6523.TWO) Earnings Analysis

Dr. Wu Skincare (6523.TWO) next reports earnings on 2026-08-19, consensus EPS 1.22 TWD. Last quarter (2026-03-04) it missed with EPS 1.94 TWD vs 2.53 TWD est (-23.3%). It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E 14.49.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 6523.TWO next report earnings?

Next earnings date2026-08-19
Consensus EPS estimate1.22 TWD
Revenue estimate0.24B

6523.TWO earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-041.94 TWD2.53 TWD-23.3%Miss
2025-03-043.1 TWD2.53 TWD+22.5%Beat

Beat rate: 1/2 (50%) over reported quarters with consensus data.

6523.TWO valuation and analyst view

Trailing P/E14.49
Trailing EPS6.208 TWD
Price / book3.01
Dividend yield11.10%
Market cap4.06B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Dr. Wu Skincare (6523.TWO)'s next earnings date?

Dr. Wu Skincare is next scheduled to report on 2026-08-19, with a consensus EPS estimate of 1.22 TWD and revenue estimate of 0.24B.

Did 6523.TWO beat earnings last quarter?

In its 2026-03-04 report, 6523.TWO posted EPS of 1.94 TWD versus a 2.53 TWD estimate — a miss of 23.3%.

What is 6523.TWO's earnings track record?

Over the last 2 reported quarters with consensus data, 6523.TWO beat estimates 1 times (50%).

What is 6523.TWO's current P/E ratio and EPS?

6523.TWO trades at a trailing P/E of 14.49 on trailing EPS of 6.208083268741003 TWD.

What do analysts rate 6523.TWO?

6523.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.